Clinical Trial Update: Relative Bioavailability of of Olodaterol and Ketoconazole [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative bioavailability of olodaterol when co-administered with ketoconazole in healthy subjects and patients with COPD; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ketoconazole (Ketoconazole)
• olodaterol (olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy, Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2014-04-30